Churchill Downs Incorporated
CHDN
$97.94
-0.24%
Churchill Downs Incorporated is a gaming entertainment, online wagering, and horse racing company operating through three segments: Live and Historical Racing (pari-mutuel and historical racing machines), Wagering Services (TwinSpires online/retail betting), and Gaming (casino properties with slots, VLTs, video poker, and ancillary hospitality). The company is best known as owner of the iconic Kentucky Derby and Churchill Downs racetrack, giving it a uniquely branded, event-driven franchise that is difficult to replicate and increasingly monetized through year-round historical racing and regional casino assets. The current investor narrative centers on the company's aggressive capital deployment into historical racing and casino expansion, margin recovery after a heavy capex cycle, and a recent definitive agreement to acquire the Preakness intellectual property rights — a move that consolidates premier racing assets and adds a new, more stable revenue stream. Shares have staged a sharp rebound off autumn lows as investors digest the latest quarter's improving profitability and a wave of reiterated bullish analyst coverage, though the stock remains down year-to-date amid elevated leverage and a still-modest top-line growth rate.…
CHDN
Churchill Downs Incorporated
$97.94
Related headlines
Investment Opinion: Should I buy CHDN Today?
Rating: Buy. The core thesis is that CHDN's heavy capex cycle is now converting into margin recovery and free cash flow — Q3 2026 EBITDA rose 23.5% to $241 million on revenue up just 1.9%, operating margin expanded to 20.55% from 14.35%, and TTM free cash flow of $529.7 million is funding active deleveraging — while the stock trades at only 13.1x forward EPS of $8.21, near the low end of its own historical PE band. That combination, reinforced by a unanimous 12-for-12 Buy consensus with a $126.83 average target (+29.9% from $97.65), makes the risk/reward favorable for patient investors willing to underwrite margin durability.
Supporting evidence is concrete: the forward PE of 13.1x versus 21.2x trailing implies roughly 38% earnings compression in the multiple, and the PS ratio of 2.76x has collapsed from 15.8x in Q4 2024 and 18.1x in Q4 2023, showing how much pessimism is already embedded. Profitability is improving — Q3 net income more than doubled to $80 million (11.49% net margin from 5.55%), Q2 delivered a 36.43% operating margin, and ROE of 37.6% (though leverage-flattered) sits alongside a 25.17% trailing operating margin. Cash generation is the linchpin: $89 million of Q3 FCF on $148 million operating cash flow against just $59 million of capex, with $198 million of debt repaid in Q1 and $154 million in Q2 2026 plus $44 million of buybacks in Q3. The EV/EBITDA of 12.13x is a premium to regional casino peers in the high-single to low-double digits, but that premium is defensible given the Derby franchise and the Preakness IP acquisition.
The biggest risks that could invalidate this thesis are (1) margin reversion — if Q3's 20.55% operating margin was racing-calendar timing rather than structural, EBITDA could fall back toward the $195 million Q3 2025 level and crush the 2.1x interest coverage; (2) the balance sheet — 5.15x debt-to-equity and a 0.60 current ratio leave little room for error, with $69 million of quarterly interest expense consuming roughly half of $143 million operating income; and (3) top-line stagnation — 1.9% Q3 revenue growth means the entire case rests on cost and asset productivity. This Buy would downgrade to Hold if operating margin falls back below 17% for two consecutive quarters or if revenue growth turns negative, and would upgrade in conviction if forward EPS estimates rise above $8.50 while the stock holds above the $99–$100 resistance. On valuation, CHDN looks modestly undervalued relative to its own history (13.1x forward versus a band that has run from ~6.5x to over 40x) and fairly valued to slightly cheap versus peers once the franchise quality premium is accounted for — not a deep-value bargain, but a reasonable price for a cash-generative, event-driven franchise in recovery.
Sign up to view all
CHDN 12-Month Price Forecast
The forward-looking case is constructive but not without conditions: CHDN's valuation at 13.1x forward earnings already discounts a meaningful earnings step-up to $8.21, and the Q3 margin expansion plus $529.7 million of TTM free cash flow suggest that step-up is achievable rather than aspirational. The unanimous sell-side stance and the $126.83 average target — which sits above the $118.35 52-week high — indicate the market's recovery narrative has room to run if execution holds. The key vulnerability is that revenue growth of just 1.9% means the entire thesis rests on margin durability and the 2.1x interest coverage cushion, so the next two earnings prints are decisive. I would upgrade to high confidence if operating margin holds above 20% for a second consecutive quarter and interest coverage improves above 2.5x through further debt paydown; I would downgrade to neutral if margin reverts below 17% or if the stock fails at $100 resistance and breaks below $90 support, signaling the late-October spike was an exhaustion gap.
Wall Street consensus
Coverage is robust and uniformly bullish: 12 analysts cover CHDN with 12 Buy ratings, 0 Hold, and 0 Sell, producing a consensus recommendation of "strong_buy" and a recommendation mean of 1.25 (where 1.0 is a strong buy). The average target price of $126.83 implies roughly +29.9% upside from the current $97.65, a substantial gap that suggests the sell-side views the recent rally as incomplete. Consensus forward EPS of $8.21 and revenue of $3.21 billion underpin those targets, and the absence of any neutral or negative ratings indicates strong conviction in the margin recovery and capital deployment story.
The target range spans $105 to $153 — a wide $48 spread (about 38% of the average target) that signals meaningful dispersion in assumptions. The low target of $105 (+7.5% upside) likely assumes modest multiple expansion and steady execution on current trends, while the high target of $153 (+56.7% upside) appears to price in successful Preakness IP monetization, continued deleveraging, and a re-rating toward historical forward multiples. Institutional activity reinforces the bullish tone: in late October 2026 alone, Mizuho, JP Morgan, and Barclays all reiterated Outperform/Overweight ratings, with Stifel (Buy), Susquehanna (Positive), Truist (Buy), Wells Fargo (Overweight), and Citizens (Market Outperform) also reaffirming — a pattern of broad-based reiteration rather than scattered upgrades, which typically follows a positive earnings catalyst. The wide spread combined with unanimous Buy ratings suggests high conviction on direction but genuine uncertainty on magnitude, and investors should note that the consensus target sits well above the 52-week high of $118.35, implying analysts expect the stock to make new highs.
Bulls vs Bears: CHDN Investment Factors
The bull case currently has stronger evidence: unanimous analyst support with a $126.83 average target, a forward PE of 13.1x near historical lows, EBITDA up 23.5% on flat revenue, and $529.7 million of TTM free cash flow funding active deleveraging. The bear case is not weak, however — 5.15x debt-to-equity, 2.1x interest coverage, and 1.9% revenue growth mean the entire thesis depends on margin durability rather than growth. The single most important tension is whether the Q3 operating-margin expansion to 20.55% (from 14.35%) is a sustainable structural improvement or a one-quarter timing artifact from the racing calendar; if margins hold, the forward multiple is too cheap, but if they revert, the leveraged balance sheet becomes the story. The stock's 0.766 beta and 28.4% one-month rally confirm the move is idiosyncratic and catalyst-driven, so the next earnings print is the decisive test.
Bullish
- Unanimous Strong Buy, 30% Upside: All 12 covering analysts rate CHDN a Buy (0 Hold, 0 Sell), producing a recommendation mean of 1.25 and a consensus target of $126.83 — roughly +29.9% above the $97.65 price. The average target also sits above the 52-week high of $118.35, implying the sell-side expects new highs within the year.
- Forward PE Compression to 13.1x: The stock trades at 21.2x trailing but just 13.1x forward earnings, a ~38% compression that implies consensus EPS of $8.21 versus the depressed trailing figure. That forward multiple is near the low end of CHDN's own historical PE band (which has ranged from ~6.5x to over 40x), suggesting pessimism is already priced in.
- Operating Leverage on Flat Revenue: Q3 2026 EBITDA rose 23.5% to $241 million (34.6% margin) from $195.1 million a year earlier even though revenue grew only 1.9% to $696 million. Operating margin expanded to 20.55% from 14.35%, and Q3 net income more than doubled to $80 million from $37.9 million — evidence that the heavy capex cycle is converting into margin recovery.
- Robust Free Cash Flow and Deleveraging: TTM free cash flow is $529.7 million, with Q3 FCF of $89 million on $148 million of operating cash flow against just $59 million of capex. Management repaid $198 million of debt in Q1 and $154 million in Q2 2026 while still buying back $44 million of stock in Q3, showing the balance sheet is being actively de-risked.
Bearish
- Leverage Is the Dominant Risk: Debt-to-equity stands at 5.15x and the current ratio is a thin 0.60, meaning short-term liabilities exceed current assets. Q3 interest expense of $69 million consumed roughly half of the $143 million in operating income, leaving interest coverage near 2.1x — a narrow cushion if EBITDA growth stalls.
- Revenue Growth Is Barely Positive: Q3 2026 revenue grew just 1.9% year-over-year to $696 million, following +4.9% in Q2 and +3.2% in Q1. The investment case therefore rests almost entirely on margin expansion and asset productivity rather than top-line acceleration, which raises the execution bar for the Preakness and casino expansion plans.
- Severe Drawdown and Volatile Tape: The stock suffered a -37.11% maximum drawdown and is down 12.77% year-to-date despite a 28.4% one-month rally off the October 7 low of $73.95. The single-session +11.2% jump on October 29 (from $81.95 to $91.16) shows the move is catalyst-driven and prone to sharp reversals.
- Premium EV/EBITDA Versus Regional Peers: EV/EBITDA of 12.13x sits at a premium to typical regional casino multiples in the high-single to low-double digits, and the 7.98x price-to-book reflects a leveraged capital structure rather than an operational premium. If the market re-rates gaming operators lower, CHDN has room to compress.
CHDN Technical Analysis
CHDN is in a recovery phase within a broader range-bound structure: the stock is up 9.90% over six months but down 0.97% over the trailing year, and down 12.77% year-to-date, reflecting a volatile, directionless twelve-month stretch punctuated by a sharp autumn drawdown. At $97.65, the stock sits roughly 84% of the way through its 52-week range of $73.09 to $118.35 — closer to the upper end but still about 17.5% below the 52-week high, positioning it as a momentum recovery rather than an overextended breakout. The maximum drawdown of -37.11% underscores how punishing the mid-year decline was, and the current level represents a meaningful retracement of that damage.
Short-term momentum is decisively positive and sharply diverging from the longer-term trend: the stock has gained 28.40% over the past month and 13.01% over three months, versus a -0.97% one-year return. This divergence is a classic mean-reversion recovery signal — the stock bottomed near $73.95 on October 7 and then exploded higher, including a single-session jump from $81.95 to $91.16 on October 29 (+11.2%) followed by $94.83 and $99.01, suggesting a fundamental catalyst (likely the late-October earnings release) rather than a slow drift. Relative strength versus SPY is strongly positive across every short window — +30.39% over one month, +15.02% over three months, and +6.79% over six months — though the one-year relative strength of -11.36% and YTD relative strength of -23.39% confirm the stock spent most of the year as a laggard. Volume of roughly 1.18 million shares on the latest session indicates active participation behind the move.
Key technical levels are well defined: support rests at the 52-week low of $73.09, with a secondary shelf around the October consolidation zone of $74–$76, while resistance sits at the 52-week high of $118.35, with an intermediate hurdle near the $99–$100 round-number area the stock just tested before pulling back 1.37% to $97.65. A decisive breakout above $100 would confirm the recovery and open a path toward the prior high, whereas a failure and breakdown below $90 would suggest the late-October spike was an exhaustion gap. The beta of 0.766 is notable — the stock is roughly 23% less volatile than the broader market, which is unusual for a consumer-cyclical gaming name and implies the recent 28% monthly move was driven by idiosyncratic, company-specific news rather than market beta; for risk management, this lower beta supports somewhat larger position sizing, but the -37.11% max drawdown and 4.24 short ratio (over four days of average volume to cover shorts) warn that squeeze-driven rallies can reverse quickly.
Beta
—
—
Max Drawdown
-37.1%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+1.4%
Cumulative gain past year
| Period | CHDN Return | S&P 500 |
|---|---|---|
| 1m | +32.4% | -5.0% |
| 3m | +11.5% | -4.9% |
| 6m | +11.1% | -0.5% |
| 1y | +1.4% | +9.6% |
| ytd | -12.5% | +7.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHDN Fundamental Analysis
Revenue growth is modest and decelerating at the headline level: Q3 2026 revenue of $696 million grew just 1.9% year-over-year against $683 million in Q3 2025, continuing a pattern of low-single-digit expansion (Q2 2026 revenue of $980 million versus $934.4 million a year earlier, roughly +4.9%, and Q1 2026's $663 million versus $642.6 million, about +3.2%). The segment mix shows Gaming as the largest contributor at $272 million, followed by Pari-Mutuel/Historical Racing at $258 million and Live & Simulcast Racing at $108 million, with other products at $83 million and racing event services at just $4 million — meaning the capital-intensive gaming and historical racing assets, not the legacy wagering business, are the growth engine. The tepid 1.9% top-line print implies the investment case rests on margin and asset productivity rather than rapid revenue acceleration, which raises the bar for execution on the Preakness IP and casino expansion.
Profitability is solid and improving on a sequential basis: Q3 2026 net income was $80 million on a 11.49% net margin, up from $37.9 million and a 5.55% net margin in Q3 2025, while gross margin came in at 29.74% versus 29.91% a year ago — essentially flat. The more telling metric is operating margin, which expanded to 20.55% in Q3 2026 from 14.35% in Q3 2025, and the seasonally strong Q2 delivered a 36.43% operating margin and 24.59% net margin, showing the business can generate robust profitability when the racing calendar and event timing cooperate. Trailing operating margin of 25.17% and net margin of 12.98% are healthy for the gambling/resorts industry, and the Q3 EBITDA of $241 million (34.6% EBITDA margin) versus $195.1 million a year ago (+23.5%) confirms operating leverage is kicking in even on flat revenue.
Balance sheet leverage is the key risk: debt-to-equity stands at a very high 5.15x, the current ratio is a thin 0.60, and interest expense of $69 million in Q3 consumed a large share of the $143 million in operating income (interest coverage of roughly 2.1x). Free cash flow is nonetheless robust at $529.7 million TTM, with Q3 2026 FCF of $89 million on $148 million of operating cash flow against $59 million of capex, and the company is actively deleveraging — Q1 2026 saw $198 million of debt repayment and Q2 another $154 million, alongside modest buybacks ($44 million in Q3). ROE of 37.6% is exceptionally high but is flattered by the leveraged capital structure (equity multiplier above 5x), while ROA of just 6.49% reveals the asset-heavy nature of the casino and racetrack base; the company generates enough cash to fund capex internally but remains dependent on refinancing and continued EBITDA growth to manage its debt load.
Quarterly Revenue
$696000000.0B
2026-09
Revenue YoY Growth
+1.9%
YoY Comparison
Gross Margin
29.7%
Latest Quarter
Free Cash Flow
$529700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHDN Overvalued?
Because net income is positive ($80 million in Q3, TTM EPS of $1.15 quarterly and $0.047 on the trailing metric), the PE ratio is the appropriate primary metric. The stock trades at a trailing PE of 21.23x against a forward PE of just 13.13x — a roughly 38% compression that implies the market expects a substantial earnings step-up, consistent with consensus EPS estimates of $8.21 for the forward period versus the depressed trailing figure. That wide trailing-to-forward gap signals the market is pricing in a normalization of earnings after a weak trailing twelve months rather than extrapolating current profitability.
On peer comparison, the picture is mixed: the PS ratio of 2.76x and EV/Sales of 3.78x are moderate for a gaming operator, but the EV/EBITDA of 12.13x sits at a premium to typical regional casino multiples in the high-single to low-double digits, reflecting the quality of the Derby franchise and historical racing growth. The PB ratio of 7.98x is elevated, though largely a function of the leveraged balance sheet rather than an operational premium, and the PEG ratio of -3.29 is not meaningful given the negative trailing earnings comparison. Relative to the broader Consumer Cyclical sector, CHDN's 21.2x trailing PE is roughly in line to modestly above market, while its 13.1x forward PE suggests the discount is warranted only if earnings delivery meets the aggressive consensus.
Historical context is instructive: CHDN's PE ratio has ranged from roughly 6.5x (Q2 2026) to over 40x (Q4 2025) and 44.9x (Q3 2025) over the past several years, and its PS ratio has compressed from 15.8x in Q4 2024 and 18.1x in Q4 2023 to just 2.76x today — a dramatic de-rating that reflects both earnings growth and multiple compression. At 21.2x trailing and 13.1x forward, the stock is now near the lower end of its own historical PE band, suggesting the market has already priced in significant pessimism; the question is whether the recent margin recovery and Preakness IP acquisition can justify re-rating toward the mid-to-high teens forward multiple the franchise historically commanded.
PE
21.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 5x~54x
vs. Industry Avg
31.9x
Industry PE ~31.9x*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by the balance sheet: debt-to-equity of 5.15x, a current ratio of just 0.60, and Q3 interest expense of $69 million against $143 million of operating income (roughly 2.1x coverage). Revenue is concentrated in capital-intensive Gaming ($272 million) and Pari-Mutuel/Historical Racing ($258 million) segments that together dwarf the $108 million Live & Simulcast business, and headline growth of only 1.9% in Q3 means any margin slippage flows straight to the bottom line. Earnings are also highly seasonal and event-dependent — Q2 2026 delivered a 36.4% operating margin versus 20.5% in Q3 — so a single weak Derby-season quarter could materially reset consensus EPS of $8.21.
Market and competitive risks center on valuation and sentiment. At 12.13x EV/EBITDA and 7.98x book, CHDN trades at a premium to regional casino peers, and its 21.2x trailing PE is in line to modestly above the Consumer Cyclical sector — leaving little cushion if growth disappoints. The beta of 0.766 means the recent 28.4% monthly move was idiosyncratic rather than market-driven, so a sector rotation out of consumer-cyclical gaming names would hit an already-extended chart; the stock is 17.5% below its 52-week high of $118.35 but only 84% through its range, and the $99–$100 resistance has already rejected it once. Regulatory and competitive threats — historical racing machine rules, online wagering competition through TwinSpires, and the integration of the Preakness IP — add event risk that is not captured in the current unanimous Buy consensus.
The worst-case scenario is a margin-reversion quarter that coincides with a refinancing or rate-driven valuation reset: if Q3's 20.55% operating margin proves to be calendar timing and revenue growth stays near 1.9%, EBITDA could fall back toward the $195 million Q3 2025 level, pressuring the 2.1x interest coverage and forcing management to pause deleveraging. In that chain, the stock would likely retest the October 7 low of $73.95 and potentially the 52-week low of $73.09 — a decline of roughly -25% from the current $97.65. A more severe outcome, consistent with the -37.11% maximum drawdown already experienced this year, would take shares toward the $61–$65 area, implying losses of -33% to -37%; the analyst low target of $105 (+7.5%) offers little downside protection if fundamentals deteriorate.
FAQ
The most severe risk is balance-sheet leverage: debt-to-equity of 5.15x, a current ratio of just 0.60, and Q3 interest expense of $69 million against $143 million of operating income (roughly 2.1x coverage) leave little cushion if EBITDA growth stalls. Second is margin durability — Q3's 20.55% operating margin versus 14.35% a year earlier could prove to be racing-calendar timing, and a reversion toward the mid-teens would invalidate the forward EPS of $8.21 that the 13.1x multiple depends on. Third is top-line stagnation: revenue grew only 1.9% in Q3 2026, so the entire thesis rests on cost control and asset productivity rather than demand acceleration, with competitive pressure on TwinSpires online wagering and soft regional casino volumes as live threats. Fourth is regulatory and event risk — adverse changes to historical racing machine rules in a key state would hit the $258 million Pari-Mutuel/Historical Racing segment, and the Preakness IP integration adds execution uncertainty. Ranked by severity: leverage first, margin reversion second, revenue stagnation third, regulatory fourth.
The 12-month forecast splits into three scenarios. The base case carries 50% probability with a $105-$126.83 range, assuming low-to-mid single-digit revenue growth, operating margins holding in the high-teens to low-20s, and forward EPS of $8.21 delivered as the multiple re-rates modestly from 13.1x toward the mid-teens. The bull case at 30% probability targets $126.83-$153, requiring Q3's margin expansion to prove structural, successful Preakness IP monetization, and a break above the $99-$100 resistance toward new highs beyond $118.35. The bear case at 20% probability targets $73.09-$105, driven by margin reversion toward the mid-teens, revenue growth stalling near 1.9%, and a re-rating of the leveraged balance sheet that retests the October 7 low of $73.95. The base case is most likely, and its key assumption is margin durability — the analyst average target of $126.83 sits above the 52-week high, so the sell-side expects new highs, but that requires the next two earnings prints to confirm the operating leverage seen in Q3.
The valuation picture depends heavily on which multiple you anchor to. Trailing PE of 21.2x looks unremarkable, but the forward PE of 13.1x implies roughly 38% earnings compression and consensus EPS of $8.21, placing the stock near the low end of its own historical range (which has touched 6.5x in Q2 2026 and exceeded 40x in Q4 2025). The PS ratio of 2.76x has collapsed from 15.8x in Q4 2024 and 18.1x in Q4 2023 — a dramatic de-rating that suggests substantial pessimism is already embedded. Against peers, EV/EBITDA of 12.13x is a premium to regional casino operators in the high-single to low-double digits, defensible given the Derby franchise and Preakness IP but leaving less room for error, while the 7.98x price-to-book reflects leverage more than operational premium. Net, CHDN looks modestly undervalued versus its own history and roughly fairly valued versus peers once franchise quality is accounted for — the market is pricing in earnings normalization, not a re-rating, so delivery of $8.21 EPS is the key variable.
On a risk/reward basis the setup is favorable but conditional: the stock trades at $97.65 against a $126.83 consensus target (+29.9% upside) with all 12 covering analysts at Buy, and the forward PE of 13.1x sits near the low end of a historical band that has ranged from roughly 6.5x to over 40x. The earnings engine is working — Q3 2026 EBITDA rose 23.5% to $241 million on revenue growth of just 1.9%, operating margin expanded to 20.55% from 14.35%, and TTM free cash flow of $529.7 million is funding debt repayment. The biggest downside risk is margin reversion: if Q3's improvement was racing-calendar timing, EBITDA could fall back toward the $195 million Q3 2025 level and the 5.15x debt-to-equity balance sheet becomes the dominant narrative, with a realistic path to the $73.09 52-week low (-25%). It is a good buy for investors with a 12-24 month horizon who can underwrite margin durability and tolerate leverage; it is a poor fit for income seekers (0.38% yield) or anyone who needs near-term certainty, given the -37.11% max drawdown already experienced this year.
CHDN is better suited to a medium-to-long-term hold than a short-term trade, though the recent tape invites tactical participation. The business is in a capex-to-cash-flow transition with $529.7 million of TTM free cash flow, active deleveraging, and a newly acquired Preakness IP asset that should compound over years — a profile that rewards patience through the margin-recovery cycle. However, earnings visibility is only moderate: revenue growth of 1.9% and heavy seasonality (Q2 2026 operating margin of 36.4% versus 20.5% in Q3) mean quarterly prints can swing sharply, and the 4.24 short ratio plus the -37.11% max drawdown warn that squeeze-driven rallies can reverse quickly. The 0.766 beta and 0.38% dividend yield confirm this is not a defensive income holding. A concrete suggested minimum holding period is 12-18 months — long enough to capture at least two more earnings cycles confirming margin durability and to see Preakness monetization begin, but short enough to reassess if the leverage profile deteriorates.